Lactation and Postpartum Involution Biology

Overview

About this study

The purpose of this study is to assess determinants of inflammation within the breast after weaning and identify approaches for reducing breast inflammation and scarring after cessation of nursing.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Postpartum women over the age of 18 years old currently weaning.
Able to provide informed consent.
Women willing to provide a survey and breast fluid specimens obtained by pumping and by hand expression.

Exclusion Criteria:

Men.
Women under the age of 18 years.
Women with a history of cancer (other than non-melanoma skin cancer).
Women with history of breast surgery.
Women taking medication to reduce milk production.
Unable to provide informed consent.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 12/22/22 Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Miriam Levi, APRN, CNM	Closed for enrollment	Contact information: Laura Pacheco-Spann M.S. (904) 953-0408 FLAQHSCS@mayo.edu
Jacksonville, Fla. Mayo Clinic principal investigator Mark Sherman, M.D.	Closed for enrollment	Contact information: Laura Pacheco-Spann M.S. (904) 953-0408 FLAQHSCS@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Miriam Levi, APRN, CNM

Closed for enrollment

Contact information:

Laura Pacheco-Spann M.S.

(904) 953-0408

FLAQHSCS@mayo.edu

Jacksonville, Fla.

Mayo Clinic principal investigator

Mark Sherman, M.D.

Closed for enrollment

Contact information:

Laura Pacheco-Spann M.S.

(904) 953-0408

FLAQHSCS@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials